Halazepam (CAS 23092-17-3) Anxiolytic Pharmaceutical API

Halazepam (CAS 23092-17-3) is a reliable benzodiazepine anxiolytic API, recognized for its targeted action in alleviating anxiety and promoting calmness. Its unique molecular structure binds to central nervous system GABA receptors, enhancing the inhibitory neurotransmitter’s effects to regulate overactive neuronal activity—effectively reducing anxiety symptoms without excessive sedation. This high-purity pharmaceutical raw material meets strict global quality standards, ensuring consistent potency and stability for formulation.

Widely used in pharmaceutical development, it serves as a core ingredient for medications treating generalized anxiety disorder and related nervous tension. Valued for its balanced efficacy and favorable safety profile, it addresses the critical need for gentle yet effective anxiety management in clinical settings. Suitable for formulating oral medications, it provides a trusted solution for pharmaceutical manufacturers aiming to improve patients’ mental well-being. Choose this premium anxiolytic API to develop high-quality formulations that deliver targeted relief.